Acadia Healthcare Company, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed by Acadia Healthcare Company, Inc. on December 17, 2019, reporting events occurring on December 13, 2019. The filing addresses corporate governance changes regarding the Board of Directors.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on the appointment of a new director and does not contain financial performance data.
Material Changes
The Board of Directors increased the number of Class II directors from two to three. Jason R. Bernhard was elected to fill the newly created vacancy. His term will expire at the 2022 annual meeting of stockholders. Mr. Bernhard is currently the Chief Operating Officer, Financial Advisory North America, and Managing Director, Head of North America Healthcare Investment Banking at Lazard Ltd.
Guidance, Outlook, and Risks
The filing does not contain financial guidance, outlook, management commentary on operations, or specific risk factors. Mr. Bernhard has not yet been assigned to any Board committees, though the Board expects to do so in the future. He will be compensated in accordance with the Company's existing plan for nonemployee directors.
Key Facts for Investor Verification
- Jason R. Bernhard was elected as a Class II director effective December 13, 2019.
- The total number of Class II directors was increased to three.
- Mr. Bernhard's term expires at the 2022 annual stockholder meeting.
- Mr. Bernhard's compensation is governed by the existing nonemployee director plan detailed in the 2019 proxy statement.
- No financial results or operational metrics are disclosed in this specific filing.